January 17, 2024 · STOCK Act disclosure
Representative Jonathan L. Jackson (Democrat-IL) bought Regeneron Pharmaceuticals, Inc., a stock transaction, valued at $1,001 - $15,000. The trade took place on January 17, 2024 and was disclosed on February 15, 2024 (owner: Joint). Members of Congress must report such transactions within 45 days under the STOCK Act.